14573-92-3

Usage

Uses

Used in Organic Synthesis:
2-[2-(DIETHYLAMINO)ETHOXY]BENZENECARBALDEHYDE is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions, contributing to the formation of complex organic molecules.
Used in Fluorescent Tagging:
In the field of molecular biology, 2-[2-(DIETHYLAMINO)ETHOXY]BENZENECARBALDEHYDE is used as a fluorescent tag for labeling proteins and peptides, enabling researchers to track and visualize these biomolecules within biological systems.
Used in Enzyme Substrate Research:
2-[2-(DIETHYLAMINO)ETHOXY]BENZENECARBALDEHYDE is used as a substrate for aldehyde dehydrogenase enzymes, playing a crucial role in studies related to enzyme function, regulation, and their implications in various biological processes.
Used in Cancer Research:
In the field of oncology, 2-[2-(DIETHYLAMINO)ETHOXY]BENZENECARBALDEHYDE is utilized in studies focused on cancer biology, potentially aiding in the understanding of cancer cell metabolism and the development of targeted therapies.
Used in Stem Cell Biology:
2-[2-(DIETHYLAMINO)ETHOXY]BENZENECARBALDEHYDE is employed in stem cell research to explore the metabolic pathways and regulatory mechanisms that govern stem cell behavior, which is vital for regenerative medicine and tissue engineering.
Used in Metabolic Studies:
2-[2-(DIETHYLAMINO)ETHOXY]BENZENECARBALDEHYDE is used in metabolic studies to investigate the role of aldehyde dehydrogenase enzymes in various metabolic pathways, contributing to a better understanding of metabolic diseases and conditions.

InChI:InChI=1/C13H19NO2/c1-3-14(4-2)9-10-16-13-8-6-5-7-12(13)11-15/h5-8,11H,3-4,9-10H2,1-2H3

Upstream product

• 242151-48-0 2-(diethylamino)ethyl iodide 
• 90-02-8 salicylaldehyde 
• 100-35-6 2-(diethylamino)ethyl chloride 

Downstream Products

• 115483-99-3 [2-(2-diethylamino-ethoxy)-benzyl]-[1-methyl-3-(2,6,6-trimethyl-cyclohex-1-enyl)-propyl]-amine 
• 63252-70-0 1-[2-(2-diethylamino-ethoxy)-phenyl]-propan-1-ol 
• 94304-09-3 {2-[2-(5-chloro-benzothiazol-2-yl)-phenoxy]-ethyl}-diethyl-amine 
• 88137-18-2 {2-[2-((E)-2-Benzo[d]isoxazol-3-yl-vinyl)-phenoxy]-ethyl}-diethyl-amine; compound with oxalic acid 
• 88136-95-2 (Z)-2-Benzo[d]isothiazol-3-yl-3-[2-(2-diethylamino-ethoxy)-phenyl]-acrylonitrile; hydrochloride 
• 88137-35-3 (Z)-2-Benzo[d]isothiazol-3-yl-3-[2-(2-diethylamino-ethoxy)-phenyl]-acrylonitrile 
• 51336-12-0 2-6-Dimethyl-4-[2-(2-diethylaminoethoxy)-phenyl]-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester 
• 63623-99-4 {2-[2-((E)-2-Cyclohexyl-vinyl)-phenoxy]-ethyl}-diethyl-amine 
• 82625-21-6 {2-[2-((Z)-2-Benzo[d]isoxazol-3-yl-2-cyano-vinyl)-phenoxy]-ethyl}-diethyl-methyl-ammonium; iodide 
• 112562-94-4 2-[2-(2-Diethylamino-ethoxy)-phenyl]-thiazolidine-3-carbothioic acid methylamide; hydrochloride 
• 35173-35-4 2-Cyclohexyl-1-[2-(2-diethylamino-ethoxy)-phenyl]-ethanol 

Relevant academic research and scientific papers

CHEMICAL COMPOUNDS 251

The invention relates to chemical compounds of formula (I), and salts thereof. In some embodiments, the invention relates to inhibitors or modulators of PIM-1 and/or PIM-2, and/or PIM-3 protein kinase activity or enzyme function. In still further embodiments, the invention relates to pharmaceutical compositions comprising compounds disclosed herein, and their use in the prevention and treatment of PIM kinase related conditions and diseases, preferably cancer.

Novel tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing the same

A compound of formula (I): wherein: represents a single or double bond, represents a ring system selected from R9a, R9b, R9c, X and Y are as defined in the description, R1 represents a group selected from hydrog